Newton, NJ, United States of America

Donald Chen-tung Hou

This inventor holds 1 USPTO granted patent. Top assignee: Schering-Plough Corporation. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Donald Chen-tung Hou. Retrieved from https://idiyas.com/inventor/donald-chen-tung-hou

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Donald Chen-tung Hou

Introduction: Donald Chen-tung Hou is a notable inventor based in Newtown, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of antitumor compounds. His work has implications for cancer treatment and showcases the importance of innovation in medical research.

Latest Patents: Donald Chen-tung Hou holds a patent for the "Synthesis of temozolomide and analogs." This invention relates to a novel process for the synthesis of Temozolomide, an antitumor compound, and its analogs. The patent also includes intermediates that are useful in this innovative process. He has 1 patent to his name.

Career Highlights: Donald is associated with Schering-Plough Corporation, where he has been involved in groundbreaking research and development. His work at the company has contributed to advancements in pharmaceutical sciences and has the potential to improve treatment options for patients.

Collaborations: Throughout his career, Donald has collaborated with esteemed colleagues, including Janet L Mas and Shen-Chun Kuo. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion: Donald Chen-tung Hou's contributions to the field of pharmaceuticals exemplify the impact of innovative thinking in medical research. His work on the synthesis of Temozolomide is a testament to the importance of inventors in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…